ichorbio
ichorbio is a manufacturer of bulk in vivo antibodies and research biosimilars based in Oxford, United Kingdom.
At ichorbio, their vision is to develop the highest quality reagents to advance scientific research and progress. They believe that the excellence of our products directly impacts the meaningfulness of research outcomes.
As a boutique reagent manufacturer, their target customers are scientists seeking reliable antibodies and other research tools. They aim to provide these products at fair prices - keeping our focus on customers, not shareholders.
Thier best selling in vivo products include RMP1-14, 10F.9G2 and 2.43. Their best selling research biosimilars include mosunetuzumab, odronextamab and aflibercept. Their best selling isotype controls include Rat IgG2a isotype control, Rat IgG2b isotype control, Human IgG1 isotype control and Human IgG4 S228P isotype control.
LifeArc
We transform promising life science ideas into medical breakthroughs that change patients’ lives.
Making life science life changing: We transform promising life science ideas into medical breakthroughs that change patients’ lives.
We specialise in early-stage translation – advancing lab-based scientific discoveries to a point at which they can be developed into the next generation of diagnostics, treatments and cures.
PrecisionLife
The PrecisionLife® platform takes a radical new approach to analysis of complex disease biology based on a wide range of patients’ genomic, clinical, and epidemiological data, enabling the discovery of richer and more useful links between patients, disease sub-groups, targets and drugs.
Our powerful patented data analytics and decision support platforms are built on a unique mathematical framework and deep experience in delivering innovative new technologies and products.
Headquartered near Oxford in the UK, we also have offices in the USA, Denmark and Poland.
